Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Samuel A. Funt, Michael Lattanzi, Karissa Whiting, +36

Journal of Clinical Oncology

Implementing a multidisciplinary approach for older adults with Cancer: geriatric oncology in practice

Carolyn J. Presley, Jessica L. Krok‐Schoen, Sarah Wall, +6

BMC Geriatrics

Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer

Benjamin C. Fu, Fred K. Tabung, Claire H. Pernar, +9

European Urology

ObesityNutritionMetabolic SyndromeUrologyBody Composition +7

Inflammatory and Insulinemic Dietary Patterns: Influence on Circulating Biomarkers and Prostate Cancer Risk

Desmond Aroke, Edmund Folefac, Ni Shi, +3

Cancer Prevention Research

FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy

Toni K. Choueiri, Harriet M. Kluger, Saby George, +17

Journal for ImmunoTherapy of Cancer

FRACTION-RCC: Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC).

Toni K. Choueiri, Harriet M. Kluger, Saby George, +15

Journal of Clinical Oncology

ImmunologyPharmacotherapyImmunotherapeuticsImmunotherapyGenitourinary Cancer +17

Low-Dose Enzalutamide in Late-Elderly Patients (≥ 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate Cancer

Vincent Vinh‐Hung, Gilles Natchagandé, Clarisse Joachim, +7

Clinical Genitourinary Cancer

UrologyOncologyLate-elderly PatientsLow-dose EnzalutamideYears Old +5

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy

Evan Gross, Mingjia Li, Ming Yin, +24

Urologic Oncology Seminars and Original Investigations

Surgical OncologyUrologyGenitourinary CancerMedicineCytoreductive Nephrectomy +6

Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low‐molecular‐weight heparin

Sandip H. Patel, Tiffany L. George, Tzu‐Fei Wang, +8

Cancer

Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer

Ming Yin, Petros Grivas, Qi-En Wang, +11

The Oncologist